Optical coherence tomography for retinal imaging in multiple sclerosis

References

• Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372(9648): 1502–1517.18970977
   PubMed Web of Science ®Google Scholar
• Balcer LJ. Clinical practice. Optic neuritis. N Engl J Med. 2006; 354(12): 1273–1280.16554529
   PubMed Web of Science ®Google Scholar
• Toosy AT, Mason DF, Miller DH. Optic neuritis. Lancet Neurol. 2014; 13(1): 83–99.24331795
   PubMed Web of Science ®Google Scholar
• Heesen C, Böhm J, Reich C, Kasper J, Goebel M, Gold SM. Patient perception of bodily functions in multiple sclerosis: gait and visual function are the most valuable. Mult Scler. 2008;14(7):988–991.18505775
   PubMed Web of Science ®Google Scholar
• Huang D, Swanson EA, Lin CP, et al Optical coherence tomography. Science. 1991;254(5035):1178–1181.1957169
   PubMed Web of Science ®Google Scholar
• Bock M, Paul F, Dörr J. [Diagnosis and monitoring of multiple sclerosis: the value of optical coherence tomography]. Nervenarzt. 2013;84(4):483–492. German.23423630
   PubMed Web of Science ®Google Scholar
• Drexler W, Fujimoto JG. State-of-the-art retinal optical coherence tomography. Prog Retin Eye Res. 2008;27(1):45–88.18036865
   PubMed Web of Science ®Google Scholar
• Parisi V, Manni G, Spadaro M, et al Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthalmol Vis Sci. 1999;40(11):2520–2527.10509645
   PubMed Web of Science ®Google Scholar
• Saidha S, Syc SB, Durbin MK, et al Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness. Mult Scler. 2011;17(12):1449–1463.21865411
   PubMed Web of Science ®Google Scholar
• Saidha S, Syc SB, Ibrahim MA, et al Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain. 2011;134(Pt 2):518–533.21252110
   PubMed Web of Science ®Google Scholar
• Syc SB, Saidha S, Newsome SD, et al Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. Brain. 2012;135(Pt 2):521–533.22006982
   PubMed Web of Science ®Google Scholar
• Oberwahrenbrock T, Ringelstein M, Jentschke S, et al Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome. Mult Scler. 2013;19(14):1887–1895.23702433
   PubMed Web of Science ®Google Scholar
• Ratchford JN, Saidha S, Sotirchos ES, et al Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning. Neurology. 2013;80(1):47–54.23267030
   PubMed Web of Science ®Google Scholar
• Narayanan D, Cheng H, Bonem KN, Saenz R, Tang RA, Frishman LJ. Tracking changes over time in retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in multiple sclerosis. Mult Scler. 2014;20(10):1331–1341.24639478
   PubMed Web of Science ®Google Scholar
• Bock M, Brandt AU, Dörr J, et al Time domain and spectral domain optical coherence tomography in multiple sclerosis: a comparative cross-sectional study. Mult Scler. 2010;16(7):893–896.20350961
   PubMed Web of Science ®Google Scholar
• Green AJ, McQuaid S, Hauser SL, Allen IV, Lyness R. Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain. 2010;133(Pt 6):1591–1601.20410146
   PubMed Web of Science ®Google Scholar
• Bock M, Brandt AU, Dörr J, et al Patterns of retinal nerve fiber layer loss in multiple sclerosis patients with or without optic neuritis and glaucoma patients. Clin Neurol Neurosurg. 2010;112(8):647–652.20452719
   PubMed Web of Science ®Google Scholar
• Oberwahrenbrock T, Schippling S, Ringelstein M, et al Retinal damage in multiple sclerosis disease subtypes measured by high-resolution optical coherence tomography. Mult Scler Int. 2012;2012:530305.22888431
   PubMedGoogle Scholar
• Siger M, Dziegielewski K, Jasek L, et al Optical coherence tomography in multiple sclerosis: thickness of the retinal nerve fiber layer as a potential measure of axonal loss and brain atrophy. J Neurol. 2008; 255(10): 1555–1560.18825432
   PubMed Web of Science ®Google Scholar
• Sepulcre J, Murie-Fernandez M, Salinas-Alaman A, García-Layana A, Bejarano B, Villoslada P. Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS. Neurology. 2007;68(18): 1488–1494.17470751
   PubMed Web of Science ®Google Scholar
• Ratchford JN, Quigg ME, Conger A, et al Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies. Neurology. 2009;73(4):302–308.19636050
   PubMed Web of Science ®Google Scholar
• Grazioli E, Zivadinov R, Weinstock-Guttman B, et al Retinal nerve fiber layer thickness is associated with brain MRI outcomes in multiple sclerosis. J Neurol Sci. 2008;268(1–2):12–17.18054962
   PubMed Web of Science ®Google Scholar
• Zaveri MS, Conger A, Salter A, et al Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis. Arch Neurol. 2008;65(7):924–928.18625859
   PubMedGoogle Scholar
• Albrecht P, Fröhlich R, Hartung HP, Kieseier BC, Methner A. Optical coherence tomography measures axonal loss in multiple sclerosis independently of optic neuritis. J Neurol. 2007;254(11):1595–1596.17987252
   PubMed Web of Science ®Google Scholar
• Costello F, Hodge W, Pan YI, Freedman M, DeMeulemeester C. Differences in retinal nerve fiber layer atrophy between multiple sclerosis subtypes. J Neurol Sci. 2009;281(1–2):74–79.19303605
   PubMed Web of Science ®Google Scholar
• Fisher JB, Jacobs DA, Markowitz CE, et al Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology. 2006;113(2):324–332.16406539
   PubMed Web of Science ®Google Scholar
• Petzold A, de Boer JF, Schippling S, et al Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol. 2010;9(9):921–932.20723847
   PubMed Web of Science ®Google Scholar
• Albrecht P, Ringelstein M, Müller AK, et al Degeneration of retinal layers in multiple sclerosis subtypes quantified by optical coherence tomography. Mult Scler. 2012;18(10):1422–1429.22389411
   PubMed Web of Science ®Google Scholar
• Outteryck O, Zephir H, Defoort S, et al Optical coherence tomography in clinically isolated syndrome: no evidence of subclinical retinal axonal loss. Arch Neurol. 2009;66(11):1373–1377.19901169
   PubMedGoogle Scholar
• Talman LS, Bisker ER, Sackel DJ, et al Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis. Ann Neurol. 2010;67(6):749–760.20517936
   PubMed Web of Science ®Google Scholar
• Serbecic N, Aboul-Enein F, Beutelspacher SC, et al High resolution spectral domain optical coherence tomography (SD-OCT) in multiple sclerosis: the first follow up study over two years. PLoS One. 2011;6(5): e19843.21611198
   PubMed Web of Science ®Google Scholar
• Parikh RS, Parikh SR, Sekhar GC, Prabakaran S, Babu JG, Thomas R. Normal age-related decay of retinal nerve fiber layer thickness. Ophthalmology. 2007;114(5):921–926.17467529
   PubMed Web of Science ®Google Scholar
• Sung KR, Wollstein G, Bilonick RA, et al Effects of age on optical coherence tomography measurements of healthy retinal nerve fiber layer, macula, and optic nerve head. Ophthalmology. 2009;116(6): 1119–1124.19376593
   PubMed Web of Science ®Google Scholar
• Alamouti B, Funk J. Retinal thickness decreases with age: an OCT study. Br J Ophthalmol. 2003;87(7):899–901.12812895
   PubMed Web of Science ®Google Scholar
• Celebi AR, Mirza GE. Age-related change in retinal nerve fiber layer thickness measured with spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2013;54(13):8095–8103.24194190
   PubMed Web of Science ®Google Scholar
• Balk LJ, Petzold A. Current and future potential of retinal optical coherence tomography in multiple sclerosis with and without optic neuritis. Neurodegener Dis Manag. 2014;4(2):165–176.24832034
   PubMedGoogle Scholar
• Vanburen JM. Trans-synaptic retrograde degeneration in the visual system of primates. J Neurol Neurosurg Psychiatry. 1963;26:402–409.14066630
   PubMed Web of Science ®Google Scholar
• Balk LJ, Steenwijk MD, Tewarie P, et al Bidirectional trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis. J Neurol Neurosurg Psychiatry. Epub June 27, 2014.
   Google Scholar
• Jindahra P, Petrie A, Plant GT. Retrograde trans-synaptic retinal ganglion cell loss identified by optical coherence tomography. Brain. 2009;132(Pt 3):628–634.19224900
   PubMed Web of Science ®Google Scholar
• Brandt AU, Oberwahrenbrock T, Ringelstein M, et al Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain. 2011;134(Pt 11):e193; author reply e194.21596763
   PubMed Web of Science ®Google Scholar
• Gelfand JM, Nolan R, Schwartz DM, Graves J, Green AJ. Microcystic macular oedema in multiple sclerosis is associated with disease severity. Brain. 2012;135(Pt 6):1786–1793.22539259
   PubMed Web of Science ®Google Scholar
• Kaufhold F, Zimmermann H, Schneider E, et al Optic neuritis is associated with inner nuclear layer thickening and microcystic macular edema independently of multiple sclerosis. PLoS One. 2013; 8(8):e71145.23940706
   PubMed Web of Science ®Google Scholar
• Saidha S, Sotirchos ES, Ibrahim MA, et al Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study. Lancet Neurol. 2012;11(11):963–972.23041237
   PubMed Web of Science ®Google Scholar
• Brandt AU, Oberwahrenbrock T, Kadas EM, Lagrèze WA, Paul F. Dynamic formation of macular microcysts independent of vitreous traction changes. Neurology. 2014;83(1):73–77.24857925
   PubMed Web of Science ®Google Scholar
• Burggraaff MC, Trieu J, de Vries-Knoppert WA, Balk L, Petzold A. The clinical spectrum of microcystic macular edema. Invest Ophthalmol Vis Sci. 2014;55(2):952–961.24398089
   PubMed Web of Science ®Google Scholar
• Barboni P, Carelli V, Savini G, Carbonelli M, La Morgia C, Sadun AA. Microcystic macular degeneration from optical neuropathy: not inflammatory, not trans-synaptic degeneration. Brain. 2013;136(Pt 7):e239.23396580
   PubMed Web of Science ®Google Scholar
• Abegg M, Dysli M, Wolf S, Kowal J, Dufour P, Zinkernagel M. Microcystic macular edema: retrograde maculopathy caused by optic neuropathy. Ophthalmology. 2014;121(1):142–149.24139122
   PubMed Web of Science ®Google Scholar
• Wolff B, Basdekidou C, Vasseur V, Mauget-Faÿsse M, Sahel JA, Vignal C. Retinal inner nuclear layer microcystic changes in optic nerve atrophy: a novel spectral-domain OCT finding. Retina. 2013;33(10): 2133–2138.23644558
   PubMed Web of Science ®Google Scholar
• Lujan BJ, Horton JC. Microcysts in the inner nuclear layer from optic atrophy are caused by retrograde trans-synaptic degeneration combined with vitreous traction on the retinal surface. Brain. 2013;136(Pt 11):e260.23872368
   PubMed Web of Science ®Google Scholar
• Winges KM, Werner JS, Harvey DJ, et al Baseline retinal nerve fiber layer thickness and macular volume quantified by OCT in the North American phase 3 fingolimod trial for relapsing-remitting multiple sclerosis. J Neuroophthalmol. 2013;33(4):322–329.24051419
   PubMed Web of Science ®Google Scholar
• Schinzel J, Zimmermann H, Paul F, et al Relations of low contrast visual acuity, quality of life and multiple sclerosis functional composite: a cross-sectional analysis. BMC Neurol. 2014;14:31.24555757
   PubMed Web of Science ®Google Scholar
• Mowry EM, Loguidice MJ, Daniels AB, et al Vision related quality of life in multiple sclerosis: correlation with new measures of low and high contrast letter acuity. J Neurol Neurosurg Psychiatry. 2009; 80(7): 767–772.19240050
   PubMed Web of Science ®Google Scholar
• Balcer LJ, Frohman EM. Evaluating loss of visual function in multiple sclerosis as measured by low-contrast letter acuity. Neurology. 2010;74 Suppl 3:S16–S23.20421569
   PubMed Web of Science ®Google Scholar
• Walter SD, Ishikawa H, Galetta KM, et al Ganglion cell loss in relation to visual disability in multiple sclerosis. Ophthalmology. 2012; 119(6): 1250–1257.22365058
   PubMed Web of Science ®Google Scholar
• Bock M, Brandt AU, Kuchenbecker J, et al Impairment of contrast visual acuity as a functional correlate of retinal nerve fibre layer thinning and total macular volume reduction in multiple sclerosis. Br J Ophthalmol. 2012;96(1):62–67.21378002
   PubMed Web of Science ®Google Scholar
• Villoslada P, Cuneo A, Gelfand J, Hauser SL, Green A. Color vision is strongly associated with retinal thinning in multiple sclerosis. Mult Scler. 2012;18(7):991–999.22291035
   PubMed Web of Science ®Google Scholar
• Almarcegui C, Dolz I, Pueyo V, et al Correlation between functional and structural assessments of the optic nerve and retina in multiple sclerosis patients. Neurophysiol Clin. 2010;40(3):129–135.20513612
   PubMed Web of Science ®Google Scholar
• Tugcu B, Soysal A, Kılıc M, et al Assessment of structural and functıonal visual outcomes in relapsing remitting multiple sclerosis with visual evoked potentials and optical coherence tomography. J Neurol Sci. 2013;335(1–2):182–185.24148562
   PubMed Web of Science ®Google Scholar
• Di Maggio G, Santangelo R, Guerrieri S, et al Optical coherence tomography and visual evoked potentials: which is more sensitive in multiple sclerosis? Mult Scler. 2014;20(10):1342–1347.24591532
   PubMed Web of Science ®Google Scholar
• Trip SA, Schlottmann PG, Jones SJ, et al Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol. 2005;58(3):383–391.16075460
   PubMed Web of Science ®Google Scholar
• Pérez-Rico C, Ayuso-Peralta L, Rubio-Pérez L, et al Evaluation of visual structural and functional factors that predict the development of multiple sclerosis in clinically isolated syndrome patients. Invest Ophthalmol Vis Sci. 2014;55(10):6127–6131.25190654
   PubMed Web of Science ®Google Scholar
• Petzold A, Wattjes MP, Costello F, et al The investigation of acute optic neuritis: a review and proposed protocol. Nat Rev Neurol. 2014; 10(8): 447–458.25002105
   PubMed Web of Science ®Google Scholar
• Gordon-Lipkin E, Chodkowski B, Reich DS, et al Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology. 2007;69(16):1603–1609.17938370
   PubMed Web of Science ®Google Scholar
• Stricker S, Oberwahrenbrock T, Zimmermann H, et al Temporal retinal nerve fiber loss in patients with spinocerebellar ataxia type 1. PLoS One. 2011;6(7):e23024.21829579
   PubMed Web of Science ®Google Scholar
• Roth NM, Saidha S, Zimmermann H, et al Photoreceptor layer thinning in idiopathic Parkinson’s disease. Mov Disord. 2014;29(9):1163–1170.24789530
   PubMed Web of Science ®Google Scholar
• Roth NM, Saidha S, Zimmermann H, et al Optical coherence tomography does not support optic nerve involvement in amyotrophic lateral sclerosis. Eur J Neurol. 2013;20(8):1170–1176.23582075
   PubMed Web of Science ®Google Scholar
• Dörr J, Wernecke KD, Bock M, et al Association of retinal and macular damage with brain atrophy in multiple sclerosis. PLoS One. 2011;6(4):e18132.21494659
   PubMed Web of Science ®Google Scholar
• Frohman EM, Dwyer MG, Frohman T, et al Relationship of optic nerve and brain conventional and non-conventional MRI measures and retinal nerve fiber layer thickness, as assessed by OCT and GDx: a pilot study. J Neurol Sci. 2009;282(1–2):96–105.19439327
   PubMed Web of Science ®Google Scholar
• Pfueller CF, Brandt AU, Schubert F, et al Metabolic changes in the visual cortex are linked to retinal nerve fiber layer thinning in multiple sclerosis. PLoS One. 2011;6(4):e18019.21494672
   PubMed Web of Science ®Google Scholar
• Saidha S, Sotirchos ES, Oh J, et al Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis. JAMA Neurol. 2013;70(1): 34–43.23318513
   PubMed Web of Science ®Google Scholar
• Young KL, Brandt AU, Petzold A, et al Loss of retinal nerve fibre layer axons indicates white but not grey matter damage in early multiple sclerosis. Eur J Neurol. 2013;20(5):803–811.23369013
   PubMed Web of Science ®Google Scholar
• Zimmermann H, Freing A, Kaufhold F, et al Optic neuritis interferes with optical coherence tomography and magnetic resonance imaging correlations. Mult Scler. 2013;19(4):443–450.22936335
   PubMed Web of Science ®Google Scholar
• Sinnecker T, Oberwahrenbrock T, Metz I, et al Optic radiation damage in multiple sclerosis is associated with visual dysfunction and retinal thinning – an ultrahigh-field MR pilot study. Eur Radiol. Epub August 17, 2014.
   Google Scholar
• Gabilondo I, Martínez-Lapiscina EH, Martínez-Heras E, et al Trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis. Ann Neurol. 2014;75(1):98–107.24114885
   PubMed Web of Science ®Google Scholar
• Balk LJ, Twisk JW, Steenwijk MD, et al A dam for retrograde axonal degeneration in multiple sclerosis? J Neurol Neurosurg Psychiatry. 2014;85(7):782–789.24474822
   PubMed Web of Science ®Google Scholar
• Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006;66(10):1485–1489.16717206
   PubMed Web of Science ®Google Scholar
• Jarius S, Wildemann B, Paul F. Neuromyelitis optica: clinical features, immunopathogenesis and treatment. Clin Exp Immunol. 2014;176(2): 149–164.24666204
   PubMed Web of Science ®Google Scholar
• Pfueller CF, Paul F. Imaging the visual pathway in neuromyelitis optica. Mult Scler Int. 2011;2011:869814.22135746
   PubMedGoogle Scholar
• Schneider E, Zimmermann H, Oberwahrenbrock T, et al Optical coherence tomography reveals distinct patterns of retinal damage in neuromyelitis optica and multiple sclerosis. PLoS One. 2013; 8(6):e66151.23805202
   PubMed Web of Science ®Google Scholar
• Bichuetti DB, de Camargo AS, Falcão AB, Gonçalves FF, Tavares IM, de Oliveira EM. The retinal nerve fiber layer of patients with neuromyelitis optica and chronic relapsing optic neuritis is more severely damaged than patients with multiple sclerosis. J Neuroophthalmol. 2013;33(3):220–224.23917443
   PubMed Web of Science ®Google Scholar
• Monteiro ML, Fernandes DB, Apóstolos-Pereira SL, Callegaro D. Quantification of retinal neural loss in patients with neuromyelitis optica and multiple sclerosis with or without optical neuritis using Fourier-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2012;53(7):3959–3966.22589446
   PubMed Web of Science ®Google Scholar
• Merle H, Olindo S, Donnio A, Richer R, Smadja D, Cabre P. Retinal peripapillary nerve fiber layer thickness in neuromyelitis optica. Invest Ophthalmol Vis Sci. 2008;49(10):4412–4417.18614811
   PubMed Web of Science ®Google Scholar
• Naismith RT, Tutlam NT, Xu J, et al Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis. Neurology. 2009;72(12):1077–1082.19307541
   PubMed Web of Science ®Google Scholar
• Lange AP, Sadjadi R, Zhu F, Alkabie S, Costello F, Traboulsee AL. Spectral-domain optical coherence tomography of retinal nerve fiber layer thickness in NMO patients. J Neuroophthalmol. 2013;33(3): 213–219.23863782
   PubMed Web of Science ®Google Scholar
• Fernandes DB, Raza AS, Nogueira RG, et al Evaluation of inner retinal layers in patients with multiple sclerosis or neuromyelitis optica using optical coherence tomography. Ophthalmology. 2013;120(2): 387–394.23084127
   PubMed Web of Science ®Google Scholar
• Sotirchos ES, Saidha S, Byraiah G, et al In vivo identification of morphologic retinal abnormalities in neuromyelitis optica. Neurology. 2013;80(15):1406–1414.23516321
   PubMed Web of Science ®Google Scholar
• Susac JO. Susac’s syndrome: the triad of microangiopathy of the brain and retina with hearing loss in young women. Neurology. 1994;44(4): 591–593.8164809
   PubMed Web of Science ®Google Scholar
• Dörr J, Radbruch H, Bock M, et al Encephalopathy, visual disturbance and hearing loss-recognizing the symptoms of Susac syndrome. Nat Rev Neurol. 2009;5(12):683–688.19953118
   PubMed Web of Science ®Google Scholar
• Dörr J, Krautwald S, Wildemann B, et al Characteristics of Susac syndrome: a review of all reported cases. Nat Rev Neurol. 2013;9(6): 307–316.23628737
   PubMed Web of Science ®Google Scholar
• Kleffner I, Duning T, Lohmann H, et al A brief review of Susac syndrome. J Neurol Sci. 2012;322(1–2):35–40.22640902
   PubMed Web of Science ®Google Scholar
• Wuerfel J, Sinnecker T, Ringelstein EB, et al Lesion morphology at 7 Tesla MRI differentiates Susac syndrome from multiple sclerosis. Mult Scler. 2012;18(11):1592–1599.22711711
   PubMed Web of Science ®Google Scholar
• Jarius S, Kleffner I, Dörr JM, et al Clinical, paraclinical and serological findings in Susac syndrome: an international multicenter study. J Neuroinflammation. 2014;11:46.24606999
   PubMed Web of Science ®Google Scholar
• Rennebohm RM, Egan RA, Susac JO. Treatment of Susac’s Syndrome. Curr Treat Options Neurol. 2008;10(1):67–74.18325301
   PubMed Web of Science ®Google Scholar
• Rennebohm R, Susac JO, Egan RA, Daroff RB. Susac’s Syndrome – update. J Neurol Sci. 2010;299(1–2):86–91.20855088
   PubMed Web of Science ®Google Scholar
• O’Halloran HS, Pearson PA, Lee WB, Susac JO, Berger JR. Microangiopathy of the brain, retina, and cochlea (Susac syndrome). A report of five cases and a review of the literature. Ophthalmology. 1998;105(6):1038–1044.9627654
   PubMed Web of Science ®Google Scholar
• Dörr J, Ringelstein M, Duning T, Kleffner I. Update on Susac syndrome: new insights in brain and retinal imaging and treatment options. J Alzheimers Dis. 2014;42 Suppl 3:S99–S108.24662104
   PubMed Web of Science ®Google Scholar
• Brandt AU, Zimmermann H, Kaufhold F, et al Patterns of retinal damage facilitate differential diagnosis between Susac syndrome and MS. PLoS One. 2012;7(6):e38741.22701702
   PubMed Web of Science ®Google Scholar
• Jenkins TM, Toosy AT. Optical coherence tomography should be part of the routine monitoring of patients with multiple sclerosis: no. Mult Scler. 2014;20(10):1299–1301.25160123
   PubMed Web of Science ®Google Scholar
• Saidha S, Calabresi PA. Optical coherence tomography should be part of the routine monitoring of patients with multiple sclerosis: yes. Mult Scler. 2014;20(10):1296–1298.25160122
   PubMed Web of Science ®Google Scholar
• Dörr J, Ohlraun S, Skarabis H, Paul F. Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial. Trials. 2012;13(1):15.22316314
   PubMed Web of Science ®Google Scholar
• Sühs KW, Hein K, Sättler MB, et al A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis. Ann Neurol. 2012;72(2):199–210.22926853
   PubMed Web of Science ®Google Scholar